Published in Curr Infect Dis Rep on October 05, 2017
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet (2013) 4.75
Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. PLoS One (2009) 3.53
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med (2010) 3.18
Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int J Syst Evol Microbiol (2010) 2.80
Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother (2012) 2.43
Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis (2003) 2.19
Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed. J Clin Microbiol (2009) 1.79
Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights. Chest (2015) 1.64
Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med (2012) 1.59
New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. J Clin Microbiol (2013) 1.43
Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol (2012) 1.38
An outbreak of bacteremias associated with Mycobacterium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol (2004) 1.28
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. J Cyst Fibros (2014) 1.16
Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients. J Clin Microbiol (2012) 1.13
The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae. Eur J Clin Microbiol Infect Dis (2012) 1.12
Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros (2014) 1.10
Transmission of M abscessus in patients with cystic fibrosis. Lancet (2013) 1.10
Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol (2013) 1.04
Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Curr Opin Pulm Med (2013) 1.04
CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother (2011) 1.04
The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea. Diagn Microbiol Infect Dis (2014) 1.02
Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacterium species, Nocardia species, and Other Aerobic Actinomycetes. J Clin Microbiol (2015) 0.97
Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis (2013) 0.97
Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis. Clin Infect Dis (2014) 0.95
Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2014) 0.95
β-Lactamase inhibition by avibactam in Mycobacterium abscessus. J Antimicrob Chemother (2014) 0.95
Nontuberculous mycobacteria in children: a changing pattern. J Otolaryngol (2005) 0.94
Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. Antimicrob Agents Chemother (2012) 0.93
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros (2012) 0.93
Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics. Int J Infect Dis (2014) 0.92
Mycobacterium abscessus Complex Infections in Humans. Emerg Infect Dis (2015) 0.91
The drug resistance profile of Mycobacterium abscessus group strains from Korea. Ann Lab Med (2013) 0.91
Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom. J Clin Microbiol (2012) 0.91
Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis (2016) 0.90
Multilocus sequence typing scheme for the Mycobacterium abscessus complex. Res Microbiol (2013) 0.90
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex. Clin Microbiol Infect (2013) 0.90
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science (2016) 0.89
Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health (2010) 0.88
Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others. Am J Respir Crit Care Med (2012) 0.88
Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing? J Clin Microbiol (2014) 0.86
Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine (Baltimore) (2016) 0.85
Cystic fibrosis and the thoracic surgeon. Eur J Cardiothorac Surg (2010) 0.83
The antimicrobial susceptibility of non-tuberculous mycobacteria. J Infect (2015) 0.83
Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Transplant Proc (2012) 0.82
In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex. Clin Microbiol Infect (2014) 0.82
Multistate US Outbreak of Rapidly Growing Mycobacterial Infections Associated with Medical Tourism to the Dominican Republic, 2013-2014(1). Emerg Infect Dis (2016) 0.82
Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex. PLoS One (2015) 0.81
Inhibition of the β-lactamase BlaMab by avibactam improves the in vitro and in vivo efficacy of imipenem against Mycobacterium abscessus. Antimicrob Agents Chemother (2017) 0.80
The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol (2016) 0.80
Rifabutin Is Active Against Mycobacterium abscessus Complex. Antimicrob Agents Chemother (2017) 0.79
Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease. Antimicrob Agents Chemother (2016) 0.79
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series. BMC Infect Dis (2016) 0.78
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis (2016) 0.78
Common presentations of nontuberculous mycobacterial infections. Pediatr Infect Dis J (2014) 0.78
A novel cluster of Mycobacterium abscessus complex revealed by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Diagn Microbiol Infect Dis (2015) 0.78
Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species. Eur Respir J (2013) 0.78
Treatment of Mycobacterium abscessus Infection. Emerg Infect Dis (2016) 0.78
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infection. Int J Infect Dis (2017) 0.77
Prevalence and Antimicrobial Susceptibility of Mycobacterium abscessus in a General Hospital, China. Biomed Environ Sci (2016) 0.77
Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols. Eur Respir J (2016) 0.77
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer. J Pediatric Infect Dis Soc (2014) 0.76
Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation. Transpl Infect Dis (2016) 0.76
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. Antimicrob Agents Chemother (2015) 0.76
Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. Antimicrob Agents Chemother (2015) 0.76
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study. Ann Am Thorac Soc (2016) 0.76
Management of Risks From Water and Ice From Ice Machines for the Very Immunocompromised Host: A Process Improvement Project Prompted by an Outbreak of Rapidly Growing Mycobacteria on a Pediatric Hematopoietic Stem Cell Transplant (Hsct) Unit. Infect Control Hosp Epidemiol (2017) 0.76
Clinical significance of respiratory isolates for Mycobacterium abscessus complex from pediatric patients. Pediatr Pulmonol (2012) 0.76
In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense. Int J Antimicrob Agents (2017) 0.76
A Laboratory-Based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. Ann Am Thorac Soc (2016) 0.76
Treatment of Non-Tuberculous Mycobacterial Lung Disease. Curr Treat Options Infect Dis (2016) 0.76
Nontuberculous mycobacterial adenitis outside of the head and neck region in children: A case report and systematic review of the literature. Int J Mycobacteriol (2016) 0.76
Infection control strategies that successfully controlled an outbreak of Mycobacterium abscessus at a cystic fibrosis center. Am J Infect Control (2015) 0.76
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database Syst Rev (2016) 0.76
Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria. J Pediatric Infect Dis Soc (2017) 0.76
Pediatric Cutaneous Nontuberculous Mycobacterium Infections in Singapore. Pediatr Dermatol (2015) 0.75
In Vitro Susceptibility Testing of Tedizolid Against Nontuberculous Mycobacteria. J Clin Microbiol (2017) 0.75
Rapidly growing mycobacteria among pediatric hematopoietic cell transplant patients traced to the hospital water supply. Pediatr Infect Dis J (2014) 0.75
Demonstration of plasmid-mediated drug resistance in Mycobacterium abscessus. J Clin Microbiol (2014) 0.75
Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. PLoS One (2016) 0.75
In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest. J Clin Microbiol (2016) 0.75
Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings. BMC Infect Dis (2016) 0.75
Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples. PLoS One (2016) 0.75